Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770482224940 Cache Key: cqdTagPageBySlug:progressive-multiple-sclerosis fetchCache[cqdTagPageBySlug:progressive-multiple-sclerosis].expirationTime: falsey fetchCache[cqdTagPageBySlug:progressive-multiple-sclerosis]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: 3697 -- Key: cqdTagPageBySlug:smatchwatch, seconds remaining: 3697 -- Key: cqdPostsByTag:cqd-migrated-tag-18480,1,10, seconds remaining: 3756 -- Key: cqdTagPageBySlug:pouchitis, seconds remaining: 3920 -- Key: cqdTagPageBySlug:cantos, seconds remaining: 3968 -- Key: cqdPostsByTag:cqd-migrated-tag-1436,1,10, seconds remaining: 3971 -- Key: cqdPostsByTag:cqd-migrated-tag-17343,1,10, seconds remaining: 4012 -- Key: cqdTagPageBySlug:race, seconds remaining: 4068 -- Key: cqdPostsByTag:cqd-migrated-tag-23206,1,10, seconds remaining: 4131 -- Key: cqdTagPageBySlug:eplilepsy, seconds remaining: 5739 -- Key: cqdPostsByTag:cqd-migrated-tag-21878,1,10, seconds remaining: 5782 -- Key: cqdTagPageBySlug:alpha-synuclein, seconds remaining: 6729 -- Key: cqdPostsByTag:cqd-migrated-tag-18477,1,10, seconds remaining: 6780 -- Key: cqdTagPageBySlug:thomas-gildea, seconds remaining: 7152 -- Key: cqdPostsByTag:cqd-migrated-tag-1009,1,10, seconds remaining: 7200 -- Key: cqdTagPageBySlug:facelift, seconds remaining: 7460 -- Key: cqdPostsByTag:cqd-migrated-tag-21412,1,10, seconds remaining: 7511 -- Key: cqdTagPageBySlug:lithium, seconds remaining: 8106 -- Key: cqdPostsByTag:cqd-migrated-tag-17776,1,10, seconds remaining: 8148 -- Key: cqdTagPageBySlug:nursing-protocols, seconds remaining: 9729 -- Key: cqdPostsByTag:cqd-migrated-tag-18599,1,10, seconds remaining: 9782 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:progressive-multiple-sclerosis - retrieving from Sanity CCCache.dataFetchCount: 10909 Cache cleanup seconds remaining: 23697
Advertisement
Advertisement
Tag: progressive multiple sclerosis
Mixed results from phase 2 CALLIPER trial of novel dual-action compound
Long-awaited efficacy against disability progression in nonrelapsing SPMS appears to be at hand
MRI classifier identifies a subset of patients with disease marked by cortical atrophy, not demyelination
Findings challenge dogma that microglia are exclusively destructive regardless of location in brain
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New review distills insights from studies over the past decade
Single-arm, open-label study offers proof of concept for MSC-NTF cells
Panel outlines research priorities around a promising alternative to imaging markers
Three criteria for finding an effective treatment for neurodegeneration
Paves way for phase 3 testing of novel treatment approach
Rendered: Sat Feb 07 2026 16:37:05 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.
Search
